Dr. Lixin Zhang, MD

Dr. Zhang practices at Dent Neurologic Institute in Amherst, New York.

Dr. Zhang's NPI, 1154482859, was assigned on December 13, 2006. Dr. Zhang holds New York license 227642.

Dr. Zhang's primary practice is Dent Neurologic Institute, at 3980 Sheridan Dr, Amherst, NY 14226-1727. The practice phone is (716) 250-2000.

Dr. Zhang's primary practice is Dent Neurologic Institute in Amherst, New York. Dr. Zhang is also affiliated with Kenmore Mercy Hospital. The medical group on file is DENT Neurologic Institute. Dmand AI also links Dr. Zhang to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Zhang is licensed in New York.

CMS data shows 4,280 Medicare services from Dr. Zhang across 31 procedure codes in 2024, for 663 Medicare patients. Medicare paid $166,738 for them. Every service was in an office.

CMS counts 663 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 250 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 58, with 63% women.

In 2024, Dr. Zhang wrote 1,785 Medicare Part D claims for 538 patients. 97% of them were for generic drugs. CMS names the drug for 1,618 of them, across 31 drugs with 11 or more claims each, at $38,136 in total drug cost. In 2023, CMS named 1,824 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 44 out of 100 for Dr. Zhang for performance year 2024, reported as part of a group. Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 67 papers to Dr. Zhang, published from 2003 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Anti-Bacterial Agents, Escherichia coli and Escherichia coli Infections. Dr. Zhang has published most often in Infect Genet Evol. Dr. Zhang's most frequent co-authors are Janet R. Gilsdorf, MD, Usha Srinivasan, MD and Bilal Bashir Butt, MD.

Dmand AI links Dr. Zhang to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Endolymphatic Hydrops, Tinnitus and Hearing Disorders.

CMS Open Payments shows 839 general payments to Dr. Zhang from 69 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Abbvie Inc. paid the most, $2,787.